The chemical class referred to as Ube1y1 Activators encompasses a range of compounds that influence the ubiquitination pathway, an essential cellular process responsible for protein degradation and signaling. These activators play a role in modulating the activity of the E1 ubiquitin-activating enzyme Ube1y1 by affecting various cellular mechanisms which, in turn, can lead to an upregulation of the enzyme's activity. The activation of Ube1y1 involves the initial step in the ubiquitination cascade: the ATP-dependent activation of ubiquitin. Enzymes in this class are not directly targeted by the activators; rather, the activators exert their influence through indirect pathways that result in the enhanced functioning of Ube1y1.
The molecules that fall under the umbrella of Ube1y1 Activators can affect the enzyme in several ways. Some compounds can induce stress responses within the cell, such as the unfolded protein response, which can elevate the need for ubiquitin-mediated degradation, thereby increasing the demand for active Ube1y1. Others may influence the ubiquitin-proteasome system by inhibiting proteasomal degradation, leading to an accumulation of ubiquitinated proteins and a consequent rise in ubiquitin recycling processes that Ube1y1 facilitates. Additionally, the modulation of signaling pathways and gene expression by certain activators can alter the landscape of protein ubiquitination, which necessitates a greater level of Ube1y1 activity to maintain protein homeostasis. By influencing the cellular environment or the abundance and folding of proteins that require ubiquitination, these activators indirectly support the heightened activity of Ube1y1 and the ubiquitination machinery it is a part of.
関連項目
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
通过抑制蛋白酶体降解,MG132 可能会增加泛素化底物,从而可能导致 Ube1y1 处理过量泛素-蛋白共轭物的活性增强。 | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Pyr-41 作为 E1 酶的抑制剂,可能会由于感知泛素激活减少的反馈机制而导致 Ube1y1 活性的补偿性上调。 | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
作为一种 HDAC 抑制剂,丁酸钠可以改变基因表达,这可能会增加泛素化底物蛋白质的表达,可能需要增强 Ube1y1 的活性。 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
通过调节 GSK-3 的活性和其他信号通路,氯化锂可能会影响蛋白质的磷酸化状态,从而可能影响其泛素化和 Ube1y1 的活性。 | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
这种酪氨酸激酶抑制剂可能会改变信号通路,进而改变泛素化格局,这可能需要增加 Ube1y1 的活性来维持体内平衡。 | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
沙利度胺以其免疫调节作用而闻名,它可能会改变免疫信号蛋白的水平,这可能需要增强泛素化酶(如 Ube1y1)的活性。 | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
与 MG132 相似,硼替佐米可能会导致降解目标蛋白的积累,从而可能导致 Ube1y1 的活性增加,以控制额外的负荷。 | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
通过诱导ER应激和未折叠蛋白反应,曲纳霉素可能会增加泛素介导的蛋白降解需求,从而可能激活Ube1y1。 | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
作为一种 Hsp90 抑制剂,格尔德霉素可能会破坏客户蛋白的稳定性,导致对泛素-蛋白酶体系统的需求增加,并可能上调 Ube1y1 的活性。 |